Richard Brudnick

Richard H.
Brudnick is currently an Independent Non-Executive Director at InflaRx NV since 2019, an Independent Director at Scholar Rock Holding Corp.
since 2023, an Independent Director at Volition America, Inc. since 2021, and a Venture Advisor at Israel Biotech Fund since 2018.
Formerly, Mr. Brudnick was President & Chief Executive Officer at James Brudnick Co., Inc. from 1984 to 1998, Independent Director at VolitionRX Ltd. from 2021 to 2023, Director at Tamarix Pharma Ltd, Senior VP-Corporate Development & Strategy at Biogen, Inc. from 2014 to 2016, Chief Business Officer & Head-Strategy at Codiak BioSciences, Inc. from 2018 to 2022, Executive Vice President-Business Development at Bioverativ, Inc. from 2016 to 2018, and Chief Business Officer at Prime Medicine, Inc. Education includes an undergraduate degree from Massachusetts Institute of Technology in 1978, an MBA from MIT Sloan School of Management in 1980, and additional undergraduate and graduate studies at MIT Sloan School of Management.